![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » NEUROMED PHARMACEUTICALS APPOINTS FORMER PFIZER SENIOR MANAGER TO EXECUTIVE TEAM
NEUROMED PHARMACEUTICALS APPOINTS FORMER PFIZER SENIOR MANAGER TO EXECUTIVE TEAM
April 10, 2006
Neuromed Pharmaceuticals, a biopharmaceutical company
developing next-generation chronic pain drugs, today announced the appointment
of Dr. Stephen Arneric to its executive team. Dr. Arneric will be Vice President
of Research and Preclinical Development responsible for the oversight of the Neuromed's
discovery and preclinical operations.
CNW
Group
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct